Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in RRMM
Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in RRMM
CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urothelial carcinoma
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer
ASCO 2019 and vision for cancer control
Better education about breast cancer treatment in Africa
A severe lack of cancer care in Burundi
Improving radiotherapy access in Africa
Cervical cancer screening in North Macedonia
The Global Health Catalyst initiative
A super-fast, cloud-based, AI imaging system for radiotherapy
Training medical physics in developing countries
Technological advances in MRD assessment